S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.96 (+0.20%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.27 (-3.49%)
GE   153.80 (-1.20%)
CGC   8.06 (+24.19%)
DIS   112.87 (-0.06%)
AMC   2.93 (-1.68%)
PFE   25.35 (-0.28%)
PYPL   62.25 (-1.60%)
XOM   118.51 (-0.10%)
S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.96 (+0.20%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.27 (-3.49%)
GE   153.80 (-1.20%)
CGC   8.06 (+24.19%)
DIS   112.87 (-0.06%)
AMC   2.93 (-1.68%)
PFE   25.35 (-0.28%)
PYPL   62.25 (-1.60%)
XOM   118.51 (-0.10%)
S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.96 (+0.20%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.27 (-3.49%)
GE   153.80 (-1.20%)
CGC   8.06 (+24.19%)
DIS   112.87 (-0.06%)
AMC   2.93 (-1.68%)
PFE   25.35 (-0.28%)
PYPL   62.25 (-1.60%)
XOM   118.51 (-0.10%)
S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.96 (+0.20%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.27 (-3.49%)
GE   153.80 (-1.20%)
CGC   8.06 (+24.19%)
DIS   112.87 (-0.06%)
AMC   2.93 (-1.68%)
PFE   25.35 (-0.28%)
PYPL   62.25 (-1.60%)
XOM   118.51 (-0.10%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conformis, Inc. stock logo
CFMS
Conformis
$2.26
$2.25
$1.05
$7.25
$17.80M1.3999,585 shs7,000 shs
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$5.18
-1.1%
$5.27
$4.22
$8.90
$59.31M0.248,288 shs8,080 shs
Histogenics Corp stock logo
HSGX
Histogenics
$1.44
-9.4%
$1.33
$0.08
$1.43
$136.22M3.19.06 million shs7.22 million shs
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$16.08
+1.8%
$16.95
$10.60
$19.66
$118.51M0.4722,763 shs20,558 shs
Sientra, Inc. stock logo
SIEN
Sientra
$0.43
$0.16
$4.94
$2.08M2.044.15 million shs3.44 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conformis, Inc. stock logo
CFMS
Conformis
0.00%0.00%0.00%0.00%+38.65%
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
+2.14%+0.19%+2.94%-0.76%-25.27%
Histogenics Corp stock logo
HSGX
Histogenics
-9.43%-20.00%+39.81%+176.92%+64.59%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-0.57%-10.58%+0.64%-9.97%+24.31%
Sientra, Inc. stock logo
SIEN
Sientra
0.00%0.00%0.00%-70.00%-90.74%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/AN/AN/AN/A
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
1.75 of 5 stars
3.53.00.00.02.70.00.6
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
4.4487 of 5 stars
0.05.01.74.92.81.73.1
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Conformis, Inc. stock logo
CFMS
Conformis
2.00
HoldN/AN/A
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
3.00
Buy$11.00112.36% Upside
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
N/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
2.00
HoldN/AN/A

Current Analyst Ratings

Latest LAKE, CFMS, CLGN, HSGX, and SIEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/5/2024
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Conformis, Inc. stock logo
CFMS
Conformis
$57.06M0.31N/AN/A$4.07 per share0.56
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$10.96M5.41N/AN/A$2.47 per share2.10
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/A($0.01) per shareN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$124.69M0.95$1.41 per share11.43$16.76 per share0.96
Sientra, Inc. stock logo
SIEN
Sientra
$90.55M0.00N/AN/A($0.04) per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Conformis, Inc. stock logo
CFMS
Conformis
-$50.47M-$5.61N/AN/AN/A-72.72%-86.46%-47.65%N/A
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
-$7.02M-$0.64N/AN/AN/A-64.05%-22.17%-18.84%5/22/2024 (Estimated)
Histogenics Corp stock logo
HSGX
Histogenics
-$8.64M-$0.79N/AN/AN/A-34.96%18.40%N/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$5.43M$0.7122.6510.94N/A4.33%6.63%5.45%6/5/2024 (Estimated)
Sientra, Inc. stock logo
SIEN
Sientra
-$73.31M-$5.57N/AN/AN/A-65.93%N/A-40.45%N/A

Latest LAKE, CFMS, CLGN, HSGX, and SIEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/10/2024Q4 2024
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.30$0.22-$0.08$0.57$32.50 million$31.20 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/A
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/AN/AN/AN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.120.75%N/A16.90%N/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/A

Latest LAKE, CFMS, CLGN, HSGX, and SIEN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2024
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Quarterly$0.030.66%2/14/20242/15/20242/22/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Conformis, Inc. stock logo
CFMS
Conformis
0.64
5.07
3.30
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A
8.62
8.40
Histogenics Corp stock logo
HSGX
Histogenics
N/A
4.05
4.05
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
0.01
5.53
2.74
Sientra, Inc. stock logo
SIEN
Sientra
N/A
0.57
0.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Conformis, Inc. stock logo
CFMS
Conformis
10.31%
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
21.69%
Histogenics Corp stock logo
HSGX
Histogenics
40.35%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
71.69%
Sientra, Inc. stock logo
SIEN
Sientra
15.38%

Insider Ownership

CompanyInsider Ownership
Conformis, Inc. stock logo
CFMS
Conformis
3.80%
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
9.60%
Histogenics Corp stock logo
HSGX
Histogenics
19.70%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
6.10%
Sientra, Inc. stock logo
SIEN
Sientra
1.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Conformis, Inc. stock logo
CFMS
Conformis
2957.88 million7.58 millionNot Optionable
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
7311.45 million10.35 millionOptionable
Histogenics Corp stock logo
HSGX
Histogenics
4994.60 millionN/ANot Optionable
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
1,7507.37 million6.92 millionOptionable
Sientra, Inc. stock logo
SIEN
Sientra
30411.96 million11.78 millionOptionable

LAKE, CFMS, CLGN, HSGX, and SIEN Headlines

SourceHeadline
Nuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis PortfolioNuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis Portfolio
finance.yahoo.com - April 18 at 3:40 PM
Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033
pharmiweb.com - April 13 at 7:57 AM
Breast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.bizBreast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.biz
pharmiweb.com - April 12 at 5:47 AM
Nasdaq (NDAQ) Initiated with a Buy at BarclaysNasdaq (NDAQ) Initiated with a Buy at Barclays
markets.businessinsider.com - April 11 at 7:34 AM
Sientra (NASDAQ:SIEN) Now Covered by StockNews.comSientra (NASDAQ:SIEN) Now Covered by StockNews.com
americanbankingnews.com - April 11 at 2:18 AM
Medical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth RateMedical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth Rate
pharmiweb.com - April 8 at 4:33 PM
Global Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI AnalysisGlobal Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI Analysis
fmiblog.com - April 4 at 6:23 PM
Aesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.usAesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.us
pharmiweb.com - April 4 at 8:22 AM
Sientra Sells Business Parts for $50M+Sientra Sells Business Parts for $50M+
ocbj.com - April 3 at 3:53 PM
Sientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
finanznachrichten.de - April 3 at 10:53 AM
Nuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment BrandNuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment Brand
finance.yahoo.com - April 3 at 10:53 AM
Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
globenewswire.com - April 2 at 6:30 PM
Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%
finance.yahoo.com - March 15 at 4:23 AM
Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032
fmiblog.com - March 14 at 11:23 PM
Firm Retention Summary: SientraFirm Retention Summary: Sientra
wsj.com - March 7 at 3:39 PM
Sientra Declares Bankruptcy, Seeks BuyerSientra Declares Bankruptcy, Seeks Buyer
ocbj.com - February 26 at 7:00 PM
Global Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMIGlobal Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMI
fmiblog.com - February 21 at 3:22 PM
SIEN Mar 2024 2.500 callSIEN Mar 2024 2.500 call
finance.yahoo.com - February 17 at 8:46 AM
Sientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessSientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
finanznachrichten.de - February 15 at 3:24 PM
Plastic surgery company goes bust, files Chapter 11 bankruptcyPlastic surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 3:24 PM
Plastic-surgery company goes bust, files Chapter 11 bankruptcyPlastic-surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 10:23 AM
Implant Maker Sientra Cleared to Draw Deerfield Bankruptcy LoanImplant Maker Sientra Cleared to Draw Deerfield Bankruptcy Loan
msn.com - February 14 at 6:42 PM
Health Care Limits Losses Amid Defensive Bias -- Health Care RoundupHealth Care Limits Losses Amid Defensive Bias -- Health Care Roundup
marketwatch.com - February 13 at 8:34 PM
Breast-Implant Maker Sientra Files for BankruptcyBreast-Implant Maker Sientra Files for Bankruptcy
wsj.com - February 13 at 8:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Conformis logo

Conformis

NASDAQ:CFMS
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
CollPlant Biotechnologies logo

CollPlant Biotechnologies

NASDAQ:CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; Tel Aviv University; Sheba Medical Center; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Histogenics logo

Histogenics

NASDAQ:HSGX
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Lakeland Industries logo

Lakeland Industries

NASDAQ:LAKE
Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.
Sientra logo

Sientra

NASDAQ:SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.